𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Correlation of C3 level with severity of generalized myasthenia gravis

✍ Scribed by Aidong Liu; Hong Lin; Yu Liu; Xinsheng Cao; Xianni Wang; Zhuyi Li

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
210 KB
Volume
40
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Use of intravenous pulsed cyclophosphami
Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis
✍ Lucas Gustavo De Feo; Juan Schottlender; NΓ©stor A. Martelli; NΓ©stor A. Molfino πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 153 KB

## Abstract Twenty‐three myasthenia gravis (MG) subjects, mean (SD) age 41.6 years (14), showing poor disease control or steroid‐related side effects, received treatment for 12 months with intravenous cyclophosphamide (CP; __n__ = 12) or placebo (PL; __n__ = 11) in a randomized, double‐blind trial.

Optimal volume of processed plasma and t
Optimal volume of processed plasma and total number of selective plasmapheresis sessions in the treatment of patients with severe generalized Myasthenia Gravis
✍ Jiann-Horng Yeh; Hou-Chang Chiu πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 47 KB πŸ‘ 2 views

The selection of the technical parameters of plasmapheresis in the treatment of patients with MG varies widely due to the lack of sufficient data from controlled studies to standardize the plasmapheresis procedure. Eight myasthenia gravis (MG) patients (Osserman IIb and III) received either immunoad